# Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

> **NCT05727605** · NA · RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 120 (estimated)

## Conditions studied

- Cognition
- Brain Tumor
- Magnetic Resonance Imaging
- Meningioma
- Glioma
- Pituitary Adenoma

## Interventions

- **BEHAVIORAL:** Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
- **DIAGNOSTIC_TEST:** MRI
- **BEHAVIORAL:** Questionnaires: EORTC QLQ C30 & BN20, STAI, CFQ, BDI-II, BRIEF-A, FACIT-F, PSQI
- **OTHER:** Toxicity scoring

## Key facts

- **NCT ID:** NCT05727605
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2026-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727605, "Neurocognition After Radiotherapy in CNS- and Skull-base Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05727605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*